CPEPmatch Webserver: A Comprehensive Tool and Database to Aid Rational Design of Cyclic Peptides for Drug Discovery

Overview

Journal Comput Struct Biotechnol J

Specialty Biotechnology

Date 2024 Sep 10

PMID 39253058

Authors

Brianda L Santini

Stephanie Wendel

Niklas Halbwedl

Asha Knipp

Martin Zacharias

Affiliations

Soon will be listed here.

Abstract

Cyclic peptides have emerged as versatile scaffolds in drug discovery due to their stability and specificity. Here, we present the cPEPmatch webserver (accessible at https://t38webservices.nat.tum.de/cpepmatch/), an easy-to-use interface for the rational design of cyclic peptides targeting protein-protein interactions combined with a semi-quantitative evaluation of binding stability. This platform also offers access to a comprehensive database of cyclic peptide crystal structures. We demonstrate the webserver's utility through a series of case studies involving medically relevant protein systems, highlighting its potential to significantly advance drug discovery efforts.

References

Case D, Cheatham 3rd T, Darden T, Gohlke H, Luo R, Merz Jr K . The Amber biomolecular simulation programs. J Comput Chem. 2005; 26(16):1668-88. PMC: 1989667. DOI: 10.1002/jcc.20290. View

Duffy F, Verniere M, Devocelle M, Bernard E, Shields D, Chubb A . CycloPs: generating virtual libraries of cyclized and constrained peptides including nonnatural amino acids. J Chem Inf Model. 2011; 51(4):829-36. DOI: 10.1021/ci100431r. View

Maier J, Martinez C, Kasavajhala K, Wickstrom L, Hauser K, Simmerling C . ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput. 2015; 11(8):3696-713. PMC: 4821407. DOI: 10.1021/acs.jctc.5b00255. View

Siegert T, Bird M, Makwana K, Kritzer J . Analysis of Loops that Mediate Protein-Protein Interactions and Translation into Submicromolar Inhibitors. J Am Chem Soc. 2016; 138(39):12876-12884. DOI: 10.1021/jacs.6b05656. View

Lin D, Tanaka Y, Iwasaki M, Gittis A, Su H, Mikami B . The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci U S A. 2008; 105(8):3011-6. PMC: 2268576. DOI: 10.1073/pnas.0712278105. View

Wang H, Liu C, Deng L . Enhanced Prediction of Hot Spots at Protein-Protein Interfaces Using Extreme Gradient Boosting. Sci Rep. 2018; 8(1):14285. PMC: 6155324. DOI: 10.1038/s41598-018-32511-1. View

Santini B, Zacharias M . Rapid Design of Potential Cyclic Peptide Binders Targeting Protein-Protein Interfaces. Front Chem. 2020; 8:573259. PMC: 7578414. DOI: 10.3389/fchem.2020.573259. View

Ji X, Nielsen A, Heinis C . Cyclic Peptides for Drug Development. Angew Chem Int Ed Engl. 2023; 63(3):e202308251. DOI: 10.1002/anie.202308251. View

Driggers E, Hale S, Lee J, Terrett N . The exploration of macrocycles for drug discovery--an underexploited structural class. Nat Rev Drug Discov. 2008; 7(7):608-24. DOI: 10.1038/nrd2590. View

10.

Abdel-Rahman S, Santini B, Calvo-Barreiro L, Zacharias M, Gabr M . Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction. Bioorg Med Chem Lett. 2024; 99:129599. DOI: 10.1016/j.bmcl.2024.129599. View

11.

Siebenmorgen T, Zacharias M . Efficient Refinement and Free Energy Scoring of Predicted Protein-Protein Complexes Using Replica Exchange with Repulsive Scaling. J Chem Inf Model. 2020; 60(11):5552-5562. DOI: 10.1021/acs.jcim.0c00853. View

12.

Naylor M, Bockus A, Blanco M, Lokey R . Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets. Curr Opin Chem Biol. 2017; 38:141-147. DOI: 10.1016/j.cbpa.2017.04.012. View

13.

Zhang Z, Lin Z, Zhou Z, Shen H, Yan S, Mayweg A . Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction. ACS Med Chem Lett. 2014; 5(9):993-8. PMC: 4160762. DOI: 10.1021/ml500160m. View

14.

Lo Conte L, Chothia C, Janin J . The atomic structure of protein-protein recognition sites. J Mol Biol. 1999; 285(5):2177-98. DOI: 10.1006/jmbi.1998.2439. View

15.

Penumutchu S, Chou R, Yu C . Structural insights into calcium-bound S100P and the V domain of the RAGE complex. PLoS One. 2014; 9(8):e103947. PMC: 4118983. DOI: 10.1371/journal.pone.0103947. View

16.

Mallinson J, Collins I . Macrocycles in new drug discovery. Future Med Chem. 2012; 4(11):1409-38. DOI: 10.4155/fmc.12.93. View

17.

Santini B, Gaardlos M, Wyrzykowski D, Rothemund S, Penk A, Zacharias M . Rational design of glycosaminoglycan binding cyclic peptides using cPEPmatch. Comput Struct Biotechnol J. 2024; 23:2985-2994. PMC: 11318538. DOI: 10.1016/j.csbj.2024.07.016. View

18.

Nwachukwu J, Srinivasan S, Zheng Y, Wang S, Min J, Dong C . Predictive features of ligand-specific signaling through the estrogen receptor. Mol Syst Biol. 2016; 12(4):864. PMC: 4848761. DOI: 10.15252/msb.20156701. View

19.

Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O . Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596(7873):583-589. PMC: 8371605. DOI: 10.1038/s41586-021-03819-2. View

20.

Bahadur R, Zacharias M . The interface of protein-protein complexes: analysis of contacts and prediction of interactions. Cell Mol Life Sci. 2007; 65(7-8):1059-72. PMC: 11131830. DOI: 10.1007/s00018-007-7451-x. View